North America Active Pharmaceutical Ingredients (API) Market, By Molecule (Small Molecule, Large Molecule), Type (Innovative Active Pharmaceutical Ingredients, Generic Innovative Active Pharmaceutical Ingredients), Type of Manufacturer (Captive API Manufacturer, Merchant API Manufacturer), Synthesis (Synthetic Active Pharmaceutical Ingredients and Biotech Active Pharmaceutical Ingredients), Chemical Synthesis (Acetaminophen, Artemisinin, Saxagliptin, Sodium Chloride, Ibuprofen, Losartan Potassium, Enoxaparin Sodium, Rufinamide, Naproxen, Tamoxifen, Others), Type of Drug (Prescription Drugs, Over-the-Counter), Usage (Clinical, Research), Potency (Low-to-Moderate Potency Active Pharmaceutical Ingredients, Potent-to-Highly Potent Active Pharmaceutical Ingredient), Therapeutic Application (Cardiology, CNS and Neurology, Oncology, Orthopedic, Endocrinology, Pulmonology, Gastroenterology, Nephrology, Ophthalmology, Other Therapeutic Application) – Industry Trends and Forecast to 2030.
North America Active Pharmaceutical Ingredients (API) Market Analysis and Size
According to the World Health Organization (WHO), cardiovascular diseases are the most significant cause of death worldwide, resulting in the deaths of 17.9 million people each year. The active pharmaceutical ingredient (API) is the substance that makes medicine work. API is a component of any medicine that generates the desired effects. Drugs are frequently made up of multiple ingredients. The API is the most important component. Excipients are other components that must be biologically innocuous and typically form a changing fraction of the medication composition. Formulation refers to optimizing and composing the mixture of components used in medicine.
Data Bridge Market Research analyses that the North America active pharmaceutical ingredients (API) market which was USD 65,951.06 million in 2022, is expected to reach USD 87,662.20 million by 2030, and is expected to undergo a CAGR of 3.6% during the forecast period 2023-2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
North America Active Pharmaceutical Ingredients (API) Market Scope and Segmentation
Report Metric |
Details |
Forecast Period |
2023 to 2030 |
Base Year |
2022 |
Historic Years |
2021 (Customizable to 2015-2020) |
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
Segments Covered |
Molecule (Small Molecule, Large Molecule), Type (Innovative Active Pharmaceutical Ingredients, Generic Innovative Active Pharmaceutical Ingredients), Type of Manufacturer (Captive API Manufacturer, Merchant API Manufacturer), Synthesis (Synthetic Active Pharmaceutical Ingredients and Biotech Active Pharmaceutical Ingredients), Chemical Synthesis (Acetaminophen, Artemisinin, Saxagliptin, Sodium Chloride, Ibuprofen, Losartan Potassium, Enoxaparin Sodium, Rufinamide, Naproxen, Tamoxifen, Others), Type of Drug (Prescription Drugs, Over-the-Counter), Usage (Clinical, Research), Potency (Low-to-Moderate Potency Active Pharmaceutical Ingredients, Potent-to-Highly Potent Active Pharmaceutical Ingredient), Therapeutic Application (Cardiology, CNS and Neurology, Oncology, Orthopedic, Endocrinology, Pulmonology, Gastroenterology, Nephrology, Ophthalmology, Other Therapeutic Application) |
Countries Covered |
U.S., Canada, Mexico |
Market Players Covered |
Dr. Reddy's Laboratories Ltd. (India), Sun Pharmaceutical Industries Ltd. (India), GlaxoSmithKline plc (U.K.), Pfizer Inc. (U.S.), Aurobindo Pharma (India), Sanofi (France), Lupin (India), Cipla Inc. (U.S.), BASF SE (Germany), Merck KGaA (Germany), Novo Nordisk A/S (Denmark), AbbVie Inc. (U.S.), Alembic Pharmaceuticals Limited (India), AstraZeneca (U.K.), Teva Pharmaceutical Industries Ltd. (Ireland), Alkem Labs (India), Saneca Pharmaceuticals (Slovakia), Jubilant Pharmova Limited (India), Neuland Laboratories Ltd (India) |
Market Opportunities |
|
Market Definition
The biological/synthetic active component of a final pharmaceutical product is an active pharmaceutical ingredient (API). Chemical synthesis, recombinant DNA, fermentation, isolation, and natural source recovery are popular API production methods. An API in a drug is used to treat, diagnose, mitigate, or prevent human health problems. It also directly influences the body's physiological functioning, restoring, correcting, or changing them. API has a wide range of applications in the pharmaceutical sector, including oncology, CNS diseases, diabetes, neurological disorders, cardiovascular and respiratory disorders, and others.
North America Active Pharmaceutical Ingredients (API) Market Dynamics
Drivers
- Increasing Prevalence of Chronic Diseases
The rising prevalence of chronic diseases such as Alzheimer's disease and others is estimated to enhance the growth of the North America active pharmaceutical ingredients (API) market. As per the Alzheimer's Association, 5.8 million people in the U.S. were living with Alzheimer's disease in 2020. This disease is the sixth biggest cause of death in the U.S., and it is more common in persons over the age of 65. This number is likely to rise to 14 million as the baby-boomer generation reaches retirement age, aggravating the situation throughout the projection period. A new case of the disease is predicted to emerge every 33 seconds by 2050.
- Increasing Investment for Healthcare Infrastructure
Another significant factor influencing the growth rate of active North America pharmaceutical ingredients (API) market is the rising healthcare expenditure which helps in improving its infrastructure. An increase in healthcare expenditure is being driven by an increase in the number of organizations conducting activities to raise awareness about hair regrowth and treatment alternatives.
Furthermore, rising initiatives by public and private organizations to spread awareness will expand the North America active pharmaceutical ingredients (API) market. In addition, rising adoption rate of organ on chip models in drug development and rising focus on precision medicine will result in the expansion of North America active pharmaceutical ingredients (API) market.
Opportunities
- Increase in the Number of Research and Development Activities
The market's growth is fuelled by an increase in the number of research and development activities. This will provide beneficial opportunities for market growth of active pharmaceutical ingredients (API). Increasing research and development (R&D) in the North American active pharmaceutical ingredients (API) market is a significant catalyst that is creating substantial opportunities for market growth. The surge in R&D activities is primarily driven by advancements in technology, a deeper understanding of diseases, and an escalating demand for innovative and effective pharmaceutical products.
- Highly Potent Active Pharmaceutical Ingredients
HPAPIs (highly potent active pharmaceutical ingredients) mark a dramatic shift in how pharmaceutical companies use small molecules to offer new medicines. As a result of the change to HPAPIs, a pipeline of more effective drugs with lower doses has emerged. HPAPIs' advantages, such as their excellent efficacy, lower therapeutic dose required (due to their selective mode of action), and capacity to bind to specific receptors, can all be attributed to their growing popularity among producers and customers.
Moreover, rising investment for the development of advanced technologies and an increase in the number of emerging markets will provide beneficial opportunities for the North America active pharmaceutical ingredients (API) market growth during the forecast period of 2023 to 2030.
Restraints/Challenges
- High cost associated with Manufacturing Processes
On the other hand, high cost high cost associated with the production process will obstruct the growth rate of market. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the market's active pharmaceutical ingredients (API). Additionally, strict regulatory policies and the negative impact of COVID-19 on the supply chain will restrain and further impede the growth rate of the market during the forecast period of 2023-2030.
This North America active pharmaceutical ingredients (API) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the North America active pharmaceutical ingredients (API) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
North America Active Pharmaceutical Ingredients (API) Market Scope
The North America active pharmaceutical ingredients (API) market is segmented on the basis of molecule, type, type of manufacturer, synthesis, chemical synthesis, type of drug, usage, potency, and therapeutic application. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Molecule
- Small Molecule
- Large Molecule
Type
- Innovative Active Pharmaceutical Ingredients
- Generic Innovative Active Pharmaceutical Ingredients
Type of Manufacturer
- Captive API Manufacturer
- Merchant API Manufacturer
Synthesis
- Synthetic Active Pharmaceutical Ingredients
- Biotech Active Pharmaceutical Ingredients
Chemical Synthesis
- Acetaminophen
- Artemisinin
- Saxagliptin
- Sodium Chloride
- Ibuprofen
- Losartan Potassium
- Enoxaparin Sodium
- Rufinamide
- Naproxen
- Tamoxifen
- Others
Type of Drug
- Prescription Drugs
- Over-the-Counter
Usage
- Clinical
- Research
Potency
- Low-to-Moderate Potency Active Pharmaceutical Ingredients
- Potent-to-Highly Potent Active Pharmaceutical Ingredient
Therapeutic Application
- Cardiology
- CNS and Neurology
- Oncology
- Orthopedic
- Endocrinology
- Pulmonology
- Gastroenterology
- Nephrology
- Ophthalmology
- Other Therapeutic Application
North America Active Pharmaceutical Ingredients (API) Market Regional Analysis/Insights
The North America active pharmaceutical ingredients (API) market is analysed and market size insights and trends are provided by country, molecule, type, type of manufacturer, synthesis, chemical synthesis, type of drug, usage, potency, and therapeutic application as referenced above.
The countries covered in the North America active pharmaceutical ingredients (API) market report are U.S., Canada, and Mexico
U.S. is the dominating and fastest growing country in the region due to prevalence of manufacturers, rise in the surge in the approvals of products for the treatment and rise in the initiatives taken by the government and pharmaceutical organizations to spread awareness regarding the disease in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the Market scenario for individual countries. Also, the presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and North America Active Pharmaceutical Ingredients (API) Market Share Analysis
The North America active pharmaceutical ingredients (API) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, North America presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to North America active pharmaceutical ingredients (API) market.
Some of the major players operating in the North America active pharmaceutical ingredients (API) market are:
- Dr. Reddy's Laboratories Ltd. (India)
- Sun Pharmaceutical Industries Ltd. (India)
- GlaxoSmithKline plc (U.K.)
- Pfizer Inc. (U.S.)
- Aurobindo Pharma (India)
- Sanofi (France)
- Lupin (India)
- Cipla Inc. (U.S.)
- BASF SE (Germany)
- Merck KGaA (Germany)
- Novo Nordisk A/S (Denmark)
- AbbVie Inc. (U.S.)
- Alembic Pharmaceuticals Limited (India)
- AstraZeneca (U.K.)
- Teva Pharmaceutical Industries Ltd. (Ireland)
- Alkem Labs (India)
- Saneca Pharmaceuticals (Slovakia)
- Jubilant Pharmova Limited (India)
- Neuland Laboratories Ltd (India)
SKU-